Muromachi Chemicals Inc.
Stock Price Chart
2026/08/25 UpdatedPrice Trend
2026/08/25 UpdatedPrice & Trading Details
2026/08/25 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥16 | -54.3% |
| 2025 | ¥35 | +59.1% |
| 2024 | ¥22 | +15.8% |
| 2023 | ¥19 | 0.0% |
| 2022 | ¥19 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥5,681M | ¥6,291M | ¥6,369M | ¥6,653M |
| Gross Profit | ¥1,733M | ¥1,752M | ¥1,855M | ¥1,960M |
| Operating Income | ¥437M | ¥369M | ¥422M | ¥432M |
| Pretax Income | ¥443M | ¥369M | ¥487M | ¥379M |
| Net Income | ¥456M | ¥256M | ¥330M | ¥241M |
| EPS | ¥112.56 | ¥64.12 | ¥81.86 | ¥59.49 |
| Operating Margin | 7.70% | 5.87% | 6.62% | 6.50% |
| Balance Sheet | ||||
| Total Assets | ¥4,798M | ¥4,948M | ¥5,059M | ¥5,265M |
| Total Equity | ¥1,681M | ¥1,915M | ¥2,271M | ¥2,452M |
| Total Liabilities | ¥3,117M | ¥3,033M | ¥2,788M | ¥2,813M |
| Cash | ¥865M | ¥853M | ¥1,050M | ¥1,058M |
| Interest-bearing Debt | ¥1,688M | ¥1,570M | ¥1,438M | ¥1,647M |
| Equity Ratio | 35.04% | 38.70% | 44.89% | 46.57% |
| D/E Ratio | 1.00 | 0.82 | 0.63 | 0.67 |
| Cash Flow | ||||
| Operating CF | ¥525M | ¥317M | ¥638M | ¥216M |
| Investing CF | -¥176M | -¥162M | -¥232M | -¥371M |
| Financing CF | -¥484M | -¥172M | -¥210M | ¥123M |
| Free CF | ¥355M | ¥207M | ¥399M | -¥120M |
| Efficiency | ||||
| ROE | 27.14% | 13.38% | 14.54% | 9.84% |
| ROA | 9.51% | 5.18% | 6.53% | 4.58% |
Latest IR Information
-
Financial Results Summary for the Fiscal Year Ending May 2026 (Japanese GAAP, Non-Consolidated)
Read more -
Financial Results Summary for the Fiscal Year Ending May 2026 [Japanese GAAP] (Non-Consolidated)
Read more -
Financial Results for the Fiscal Year Ending May 2026 (Japanese GAAP, Non-Consolidated)
Read more
Latest News (5 items)
Company Information
About
Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals, health foods, and chemicals in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharmaceuticals; and commissioned synthesis services, including GLP analysis, storage, stability testing, and repurification of radioisotopes. The company also provides traditional tablets; jelly; and non-alcoholic beverage products. In addition, it offers ion-exchange resins; separation membranes; water-treatment products; and contract processing services. Further, it provides functional adhesives; product contamination removal and dust removal mats, and antistatic products for use in the electronics industry; and engages in the commissioned manufacturing and processing of functional pastes. The company was founded in 1917 and is headquartered in Omuta, Japan.
